{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:04:05Z","timestamp":1785528245713,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Metab Health Dis"],"DOI":"10.1038\/s44324-026-00123-3","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:30:18Z","timestamp":1785324618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding regional differences in MASLD: the Indian perspective"],"prefix":"10.1038","volume":"4","author":[{"given":"Karthik","family":"Shree Harini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraj","family":"Ezhilarasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"123_CR1","doi-asserted-by":"crossref","unstructured":"Chan, W. K. et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J. Obes. Metab. Syndr. 32, 197\u2013213 (2023).","DOI":"10.7570\/jomes23052"},{"key":"123_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"123_CR3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 31, S32\u2013S50 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"123_CR4","first-page":"435","volume":"12","author":"S Kannan","year":"2024","unstructured":"Kannan, S. et al. Evaluation of risk factors for non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J. Educ. Health Promot 12, 435 (2024).","journal-title":"J. Educ. Health Promot"},{"key":"123_CR5","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.jhep.2025.03.005","volume":"83","author":"LY Mak","year":"2025","unstructured":"Mak, L. Y., Yip, T. C., Lee, C. H., Lai, J. C. & Wong, V. W. Underrepresentation of Asians in diagnostic test development and drug trials in MASLD. J. Hepatol. 83, e59\u2013e60 (2025).","journal-title":"J. Hepatol."},{"key":"123_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12944-025-02750-z","volume":"24","author":"J Zeng","year":"2025","unstructured":"Zeng, J., Gu, C., Wen, C. & Shen, C. The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India. Lipids Health Dis. 24, 298 (2025).","journal-title":"Lipids Health Dis."},{"key":"123_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s13300-025-01748-1","volume":"16","author":"V Mohan","year":"2025","unstructured":"Mohan, V. et al. Prevalence of metabolic dysfunction-associated steatotic liver disease: mapping across different indian populations (MAP Study). Diab. Ther. 16, 1435\u20131450 (2025).","journal-title":"Diab. Ther."},{"key":"123_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar et al. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J. Clin. Exp. Hepatol. 12, 818\u2013829 (2022).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"123_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.4103\/ijcm.ijcm_437_22","volume":"48","author":"MC Anton","year":"2023","unstructured":"Anton, M. C., Shanthi, B. & Sridevi, C. Prevalence of non-alcoholic fatty liver disease in urban adult population in a tertiary care center, Chennai. Indian J. Community Med 48, 601\u2013604 (2023).","journal-title":"Indian J. Community Med"},{"key":"123_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan, J. G., Kim, S. U. & Wong, V. W. New trends on obesity and NAFLD in Asia. J. Hepatol. 67, 862\u2013873 (2017).","journal-title":"J. Hepatol."},{"key":"123_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biomedicines9101346","volume":"9","author":"MS Kuchay","year":"2021","unstructured":"Kuchay, M. S., Mart\u00ednez-Montoro, J. I., Choudhary, N. S., Fern\u00e1ndez-Garc\u00eda, J. C. & Ramos-Molina, B. Non-alcoholic fatty liver disease in lean and non-obese individuals: current and future challenges. Biomedicines 9, 1346 (2021).","journal-title":"Biomedicines"},{"key":"123_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jceh.2015.09.001","volume":"5","author":"SP Singh","year":"2015","unstructured":"Singh, S. P. et al. Risk factors associated with non-alcoholic fatty liver disease in Indians: a case-control study. J. Clin. Exp. Hepatol. 5, 295\u2013302 (2015).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"123_CR13","unstructured":"Chakrabarti, S. K. & Chattopadhyay, D. India's hidden liver crisis: understanding MASLD (formerly NAFLD) through a precision lens. Int. J. Med. Case Rep. Rev. 5, 1\u201314 (2025)."},{"key":"123_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/cld.1141","volume":"18","author":"A De","year":"2021","unstructured":"De, A. & Duseja, A. Nonalcoholic fatty liver disease: Indian perspective. Clin. Liver Dis. 18, 158\u2013163 (2021).","journal-title":"Clin. Liver Dis."},{"key":"123_CR15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s42452-025-07243-3","volume":"7","author":"D Sharma","year":"2025","unstructured":"Sharma, D. et al. Hepatic steatosis: associated rs2954029 and rs2605100 genetic factors in an Indian population. Discov. Appl. Sci. 7, 1105 (2025).","journal-title":"Discov. Appl. Sci."},{"key":"123_CR16","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4254\/wjh.v9.i26.1101","volume":"9","author":"G Bale","year":"2017","unstructured":"Bale, G. et al. Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities. World J. Hepatol. 9, 1101\u20131107 (2017).","journal-title":"World J. Hepatol."},{"key":"123_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4082\/kjfm.25.0027","volume":"46","author":"D Lorek","year":"2025","unstructured":"Lorek, D. et al. The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: understanding inequalities in prevalence and outcomes. Korean J. Fam. Med. 46, 61\u201369 (2025).","journal-title":"Korean J. Fam. Med."},{"key":"123_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi, E. et al. Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries. Arch. Med Res 55, 103043 (2024).","journal-title":"Arch. Med Res"},{"key":"123_CR19","volume":"17","author":"P Budhwani","year":"2025","unstructured":"Budhwani, P., Goswani, B., Debnath, S. & Shukla, A. Prevalence of metabolic dysfunction-associated steatotic liver disease among overweight and obese patients with type 2 diabetes mellitus. Cureus 17, e99670 (2025).","journal-title":"Cureus"},{"key":"123_CR20","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 22, 1999\u20132010.e8 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"123_CR21","doi-asserted-by":"crossref","unstructured":"Arvind, M. et al. Unveiling the burden of MASLD and liver fibrosis in India: novel insights from the Phenome India study into fibrosis without MASLD. medRxiv, https:\/\/www.medrxiv.org\/content\/10.1101\/2025.10.11.25337761v1 (2025).","DOI":"10.1101\/2025.10.11.25337761"},{"key":"123_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2025.102596","volume":"49","author":"D Ezhilarasan","year":"2025","unstructured":"Ezhilarasan, D. MASLD progression in India: a growing concern in the world\u2019s diabetes capital. Clin. Res. Hepatol. Gastroenterol. 49, 102596 (2025).","journal-title":"Clin. Res. Hepatol. Gastroenterol."}],"container-title":["npj Metabolic Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00123-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00123-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00123-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:03Z","timestamp":1785521943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00123-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1038\/s44324-026-00123-3","relation":{},"ISSN":["2948-2828"],"issn-type":[{"value":"2948-2828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"30"}}